Program

IS PROGRESSIVE ß-CELL DYSFUNCTION IN TYPE 2 DIABETES INEVITABLE? Lawrence Blonde, MD, FACP, FACE Oschner Clinic Foundation, New Orleans, Louisiana	[ Modem ] [ DSL ]	Modem/DSL
Presented by Derek LeRoith MD, PhD, FACP Mount Sinai School of Medicine, New York, New York
THE PROMISE OF INCRETIN THERAPIES: DATA FROM CLINICAL TRIALS William T. Cefalu, MD Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana	[ Modem ] [ DSL ]	Modem/DSL
THE PROMISE OF INSULIN: DATA FROM CLINICAL TRIALS WITH TRADITIONAL AND NONINVASIVE FORMULATIONS Julio Rosenstock, MD Dallas Diabetes and Endocrine Center, Dallas, Texas	[ Modem ] [ DSL ]	Modem/DSL
PANEL DISCUSSION AND Q & A Panel	[ Modem ] [ DSL ]	Modem/DSL

If you have viewed all of the webcast presentations, click here to complete the Verification of Credit and Program Evaluation Form (Microsoft^® Word). Once completed, return the forms by mail or fax to Tulane University to obtain CME credit.